[ET Net News Agency, 21 June 2021] WUXI BIO (02269) rose 4.84% to HK$138.5.
It hits an intra-day high of HK$140, hitting a historical high, and an intra-day low of
HK$129.5. The total shares traded was 5.3 million, with a value of HK$711.75m. The active
buy/sell ratio is 63:37, with net buying turnover of HK$146.48m. MORGAN STANLEY HK SEC
accounts for greatest net responsive buying turnover of HK$22.52m, with volume weighted
average price of HK$134.942. MERRILL LYNCH FE accounts for greatest net responsive selling
turnover of HK$31.05m, with volume weighted average price of HK$135.382. The stock has
risen a combined 18.48% over the past 3 consecutive trading days.
The Hang Seng Index now fell 325 points, or 1.13% to 28,475; the Hang Seng China
Enterprises Index now fell 107 points, or 1.01% to 10,539; the Hang Seng TECH Index now
fell 110 points, or 1.37% to 7,931; with an overall turnover of HK$21.05b.
The SSE Composite Index now fell 8 points, or 0.26% to 3,516, with an overall turnover
of RMB64.49b.
The SZSE Component Index now fell 14 points, or 0.1% to 14,568, with an overall turnover
of RMB43.18b.
Basic Information
-------------------------------------------
Nominal 138.500 % Chg +4.84%
High 140.000 Low 129.500
Shares Tr 5.3m Turnover 711.75m
10-D SMA 123.960 %H.V 54.042
20-D SMA 121.390 VWAP 134.240
50-D SMA 112.834 RSI14 70.627
-------------------------------------------
Status: Hitting a historical high, active buy/sell ratio is 63:37, with net buying
turnover of HK$146.48m, rising a combined 18.48% over the past 3 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
WUXI BIO (02269) 138.50 +4.84
GENSCRIPT BIO (01548) 32.15 -2.13
INNOVENT BIO (01801) 85.20 -1.56
JXR (01951) 19.62 +6.63
JW THERAP-B (02126) 29.95 +5.83
CARSGEN-B (02171) 30.95 +3.17
CSTONE PHARMA-B (02616) 18.38 +8.24
BEIGENE (06160) 194.00 +1.15
CANSINOBIO-B (06185) 357.00 Unchanged
ALPHAMAB-B (09966) 22.40 +5.41
-------------------------------------------------
(ed)